Yunnan Botanee Bio-Technology Group Co.LTD (SHE:300957)

SHE:300957 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	5,273	5,707	5,707	4,998	4,008	2,621
Other Revenue	29.57	29.11	20.55	16.12	14.63	15.91
Revenue	5,303	5,736	5,727	5,014	4,022	2,636
Revenue Growth (YoY)	-13.97%	0.15%	14.23%	24.65%	52.57%	35.64%
Cost of Revenue	1,335	1,565	1,462	1,262	977.08	635.17
Gross Profit	3,968	4,170	4,266	3,752	3,045	2,001
Selling, General & Admin	3,404	3,379	3,023	2,391	1,926	1,276
Research & Development	297.31	295.17	298.82	254.7	113.22	63.44
Other Operating Expenses	114.41	63.06	47.45	54.71	52.12	10.77
Operating Expenses	3,819	3,750	3,382	2,700	2,097	1,355
Operating Income	149.47	420.76	883.6	1,052	948.45	645.86
Interest Expense	-22.67	-17.59	-4.97	-4.75	-4.19	-1.33
Interest & Investment Income	87.2	82.5	92.91	100.88	33.62	5.7
Currency Exchange Gain (Loss)	-1.32	-1.23	-0.72	0.03	-0	-
Other Non Operating Income (Expenses)	7.31	-1.13	-215.84	-1.72	-0.53	-2.21
EBT Excluding Unusual Items	219.98	483.32	754.97	1,147	977.35	648.01
Impairment of Goodwill	-90.69	-90.69	-	-	-	-
Gain (Loss) on Sale of Investments	176.3	177.55	-17.24	-5.52	10.8	-
Gain (Loss) on Sale of Assets	-0.05	-4.15	0.69	-0.03	0.52	-0.17
Asset Writedown	-25	-25	-	-	-	-
Other Unusual Items	90.22	67.37	130.39	72.75	29.21	-
Pretax Income	370.76	608.4	868.82	1,214	1,018	647.84
Income Tax Expense	103.11	113.61	109.61	163.33	153.81	104.08
Earnings From Continuing Operations	267.65	494.79	759.21	1,051	864.06	543.75
Minority Interest in Earnings	-1.7	8.26	-2.42	0.8	-1.14	-0.25
Net Income	265.95	503.05	756.8	1,051	862.92	543.51
Net Income to Common	265.95	503.05	756.8	1,051	862.92	543.51
Net Income Growth	-66.36%	-33.53%	-28.02%	21.83%	58.77%	31.94%
Shares Outstanding (Basic)	422	419	423	424	407	360
Shares Outstanding (Diluted)	422	419	423	424	407	360
Shares Change (YoY)	0.16%	-0.85%	-0.27%	4.15%	13.09%	-0.39%
EPS (Basic)	0.63	1.20	1.79	2.48	2.12	1.51
EPS (Diluted)	0.63	1.20	1.79	2.48	2.12	1.51
EPS Growth	-66.41%	-32.96%	-27.82%	16.98%	40.40%	32.46%
Free Cash Flow	287.59	316.48	336.16	416.02	882.04	341.57
Free Cash Flow Per Share	0.68	0.76	0.80	0.98	2.17	0.95
Dividend Per Share	0.600	0.600	0.600	0.800	0.600	0.450
Dividend Growth	-0.08%	-0.08%	-24.94%	33.33%	33.33%	60.71%
Gross Margin	74.83%	72.71%	74.48%	74.83%	75.71%	75.91%
Operating Margin	2.82%	7.34%	15.43%	20.99%	23.58%	24.50%
Profit Margin	5.01%	8.77%	13.21%	20.97%	21.45%	20.61%
Free Cash Flow Margin	5.42%	5.52%	5.87%	8.30%	21.93%	12.96%
EBITDA	238.91	516.08	954.32	1,110	968.11	659.61
EBITDA Margin	4.50%	9.00%	16.66%	22.15%	24.07%	25.02%
D&A For EBITDA	89.44	95.32	70.72	58.23	19.66	13.74
EBIT	149.47	420.76	883.6	1,052	948.45	645.86
EBIT Margin	2.82%	7.34%	15.43%	20.99%	23.58%	24.50%
Effective Tax Rate	27.81%	18.67%	12.62%	13.46%	15.11%	16.07%
Revenue as Reported	5,303	5,736	5,522	5,014	4,022	2,636
Advertising Expenses	-	2,046	1,922	1,534	1,249	811.84

Source: S&P Global Market Intelligence. Standard template. Financial Sources.